Trial Profile
A single-center, prospective pilot study to elucidate the fluorescence diagnostic ability of 5-aminolevulinic acid for cholangiocarcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2019
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Cholangiocarcinoma
- Focus Diagnostic use
- 24 Sep 2019 Status changed to completed.
- 04 Apr 2017 New trial record